Should the FDA mandate that autologous units drawn and transfused within a single institution be tested for markers of infectious disease?
| Autor: | Arell Shapiro, L. Kaminer, Marie E. Cannon, Lawrence D. Petz, Walter H. Dzik, Lynne Uhl, Mary O'Neill, Mark A. Popovsky, James P. AuBuchon, Margot S. Kruskall, Karen King, Herbert Silver, Roslyn Yomtovian, Paul M. Ness, James T. Perkins |
|---|---|
| Rok vydání: | 2000 |
| Předmět: |
medicine.medical_specialty
Medical Errors United States Food and Drug Administration business.industry Immunology Hematology Communicable Diseases United States Surgery Blood Transfusion Autologous Infectious disease (medical specialty) Communicable Disease Control medicine Humans Immunology and Allergy Mandate Economics Hospital Safety Single institution Intensive care medicine business |
| Zdroj: | Transfusion. 40:752-753 |
| ISSN: | 1537-2995 0041-1132 |
| DOI: | 10.1046/j.1537-2995.2000.40060752.x |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text